Clinical Trial Update: Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea

View source ↗

Summary

A Korea-based clinical trial is evaluating trastuzumab emtansine (T-DM1) after prior treatment with trastuzumab deruxtecan (T-DXd) in HER2-positive breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab Deruxtecan (Enhertu) (trastuzumab deruxtecan)
• Trastuzumab Emtansine (Kadcyla) (trastuzumab emtansine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Cancer of Breast, Trastuzumab Emtansine | Status: RECRUITING